Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
analysis
Now Is A Good Time To Buy Dendreon
Now Is A Good Time To Buy Dendreon
Seeking Alpha
analysis
Dendreon
Deutsche Bank Expects Pharmaceutical Sector To Outperform
Deutsche Bank Expects Pharmaceutical Sector To Outperform
iStockAnalyst
analysis
Analyst touts Pharmasset shares
Analyst touts Pharmasset shares
Yahoo/AP
analysis
hepatitis C
Pharmasset
PSI-7977
Could Amgen Be Hiding Weakness?
Could Amgen Be Hiding Weakness?
Motley Fool
Amgen
analysis
Submitted by
moderatorj
on Mon, 06/06/2011 - 13:01
Digital sound analysis could improve heart disease diagnosis | Research roundup
Digital sound analysis could improve heart disease diagnosis | Research roundup
Mass Device
analysis
diagnosis
heart disease
research
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT